{"name":"Sinphar Pharmaceutical Co., Ltd","slug":"sinphar-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Ergoloid Mesylates tablet","genericName":"Ergoloid Mesylates tablet","slug":"ergoloid-mesylates-tablet","indication":"Other","status":"phase_2"},{"name":"Orectalip","genericName":"Orectalip","slug":"orectalip","indication":"Other","status":"marketed"},{"name":"STA-1","genericName":"STA-1","slug":"sta-1","indication":"Other","status":"phase_2"},{"name":"STA-2","genericName":"STA-2","slug":"sta-2","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Ergoloid Mesylates tablet","genericName":"Ergoloid Mesylates tablet","slug":"ergoloid-mesylates-tablet","phase":"phase_2","mechanism":"Acts as a mixed alpha-adrenergic antagonist and dopaminergic agonist to enhance cerebral metabolism and neurotransmitter function.","indications":[],"catalyst":""},{"name":"Orectalip","genericName":"Orectalip","slug":"orectalip","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"STA-1","genericName":"STA-1","slug":"sta-1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"STA-2","genericName":"STA-2","slug":"sta-2","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNZXU1Y0phNzg4LXltaTV6QWQ4ZnMtajRBQ0k1SFZRYnJrUWw5LXNNenlUUWRXSVRmelZuNnRqcGtYdjZmU3VieVl0aUtmZVlUSWNSRGEzUXdjUm9IcWNiMkJxTExfZWM2VlhoV3MyMGYxai1KdEg4OUUxX3FqVEl6VF94blU2eF9mZXN0N3NVd3hDcmc?oc=5","date":"2023-01-12","type":"earnings","source":"全球醫療採購網","summary":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","headline":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPSVZXTVp4X0hZbGtTYVVocmMwTEZDS3ZIRms5N2pLSkUtYlJrVWNVUThyOFYySTlUVDZiendGMEJUdDNNWlM4ajVMT2Fma3hETFZSQlJHM0RWUXNoMmhmUU9XOHRSSk1Ubmlvei02VFUyemtaRlhSdDUyN0NyWEdGamhNczZwcVBnd0JaMjc2dURGY2RLZTZFMW5rZGk?oc=5","date":"2022-07-25","type":"regulatory","source":"globaldata.com","summary":"Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape - globaldata.com","headline":"Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdi1vOG1BWC1ER3ZzbFNHOHdaWnFUY0lDTEFjOFFHTU9CYWFfdWR2VGpWV21TenNvNVNuTjdLZnN1ZUk5M0o3TVd5QmZMNllYRzcyWXVDRjNlM0ZJUWVzaUJSVHFVamdLM2QzZktteC1lUENpRVB1QndCUVBGN1ZGREQwVHN5S1g1ZmpjWVphU2pUT3Z6NHRoVnVfdw?oc=5","date":"2021-09-24","type":"pipeline","source":"Pharmaceutical Technology","summary":"Taiwan offers advanced pharma manufacturing potential - Pharmaceutical Technology","headline":"Taiwan offers advanced pharma manufacturing potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1lNDQyN1RkZGJFUjd0cUZhVnkyOHhxSDlYMFBlYi1sZW1wbzY5dXpCSVk2eV95blNnYVBfN054LS11WFhoTlg3N3BKMktvWTFjdGRNa0Nn?oc=5","date":"2017-06-12","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5PSUVBMlY4QURwUFgyc05COGc4YTVMWlkzdFByRFA3dVIwLXdUcmkxTl95eURobmsxUGVoM1MzNEJmS0tLcGxhXzFVcWU4cXNIZzRVQnlZOFp2ZVNLVW42a3BFOG1fdw?oc=5","date":"2013-07-18","type":"pipeline","source":"天下雜誌","summary":"Old Pharma Shifts to New Cancer Drugs｜Insight｜2013-07-18 - 天下雜誌","headline":"Old Pharma Shifts to New Cancer Drugs｜Insight｜2013-07-18 - 天下雜誌","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":3,"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}